³í¹®) Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin’s lymphoma °¡Å縯´ë ¿©Àǵµ¼º¸ðº´¿ø ¸²ÇÁÁ¾¼¾ÅÍ Á¶¼®±¸·Àü¿µ¿ì ±³¼öÆÀ